First in vivo study of the MDM2/X-p53 antagonist PM2 as potentiator of external radiotherapy in wt p53 cancer
2018
First in vivo study of the MDM2/X-p53 antagonist PM2 as potentiator of external radiotherapy in wt p53 cancer
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI